Literature DB >> 697353

In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.

J R DiPersio, T L Krafczyk.   

Abstract

The in vitro inhibitory activity of rosamicin and erythromycin against 283 strains of nonfermenting, gram-negative bacilli was determined by using a broth dilution procedure. Rosamicin demonstrated greater activity than erythromycin against most strains tested. A number of species demonstrated significantly lower minimum inhibitory concentrations to rosamicin and would fall within the therapeutic range of the drug based on current pharmacological data.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 697353      PMCID： PMC352446          DOI： 10.1128/AAC.14.2.274

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Rosamicin: in vitro activity against anaerobes and comparison with erythromycin.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

2.  Rosamicin in urethral and vaginal secretions and tissues in dogs and rats.

Authors:  U Hoyme; A Baumueller; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

3.  Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.

Authors:  J A Waitz; C G Drube; E L Moss; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1972-11       Impact factor: 2.649

4.  Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.

Authors:  C C Crowe; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

5.  A new Micromonospora-produced macrolide antibiotic, rosamicin.

Authors:  G H Wagman; J A Waitz; J Marquez; A Murawaski; E M Oden; R T Testa; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1972-11       Impact factor: 2.649

6.  Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.

Authors:  S Shadomy; M Tipple; L Paxton
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

7.  In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.

Authors:  J Santoro; D Kaye; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

8.  In vitro activity of rosamicin against Neisseria and Haemophilus, including penicillinase-producing strains.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

9.  Rosamicin--a new drug for the treatment of bacterial prostatitis.

Authors:  A Baumueller; U Hoyme; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.